The controversial approval of an Alzheimer’s drug reignites the battle over the underlying cause of the disease

The field of Alzheimer’s research has been dominated — and divided — by a hypothesis holding that toxic clumps in the brain are the main driver of the disease and that removing them will slow cognitive decline.

View original article
Contributor: Laurie McGinley